A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced nine abstracts were accepted for presentation at the ...

The international registry will track patient outcomes over time and allow UCLH to quality control the dissemination of NanoKnife, explained Mark Emberton, professor of interventional oncology ...

The international registry will track patient outcomes over time and allow UCLH to quality control the dissemination of NanoKnife, explained Mark Emberton, professor of interventional oncology within ...

He is also a founding member of the Society of Interventional Oncology and has served as a mentor to junior faculty at local universities, including Roger Williams University. Dr. Park attributes ...

He is also a founding member of the Society of Interventional Oncology and has served as a mentor to junior faculty at local universities, including Roger Williams University. Dr. Park attributes his ...

TRANSFORMING CARDIOVASCULAR CARE FOR ALL STARTS HERE! Join the American College of Cardiology (ACC) and the Egyptian Society of Cardiology for ACC Middle East 2024! Designed to elevate your practice ...